BioSight
Companies
Kura Oncology, Inc. logo

KURA

NASDAQSAN DIEGO, CA
Kura Oncology, Inc.

Kura Oncology is a biotech company developing treatments for cancer, with a commercialized product called KOMZIFTI and a pipeline of additional product candidates in development. The excerpt does not provide specific details about Kura's therapeutic modalities or the exact development stage of its pipeline beyond indicating that KOMZIFTI has already obtained regulatory approval and is being commercialized.

Price history not yet available for KURA.

Pipeline

No pipeline data on record yet.

Catalyst Calendar

No catalyst events on record for yet. Check back after the next daily ingest.

Disclaimer·BioSight aggregates publicly available data (SEC EDGAR, ClinicalTrials.gov, FDA, company press releases) and is provided as is for informational purposes only. Nothing here is investment, financial, legal, tax, or medical advice, or an offer to buy or sell any security. We make no warranty as to accuracy, completeness, or timeliness; dates and filings may contain errors or be superseded without notice; past events do not predict future outcomes. To the maximum extent permitted by law, BioSight, its operators, contributors, and affiliates disclaim all liability for any loss or damage arising from use of or reliance on this site. You are solely responsible for your own investment decisions — consult a licensed professional before acting on any information.

Unlock 12-month calendar